Stocks · Health care · Biological Products, (No Diagnostic Substances)

NEUROCRINE BIOSCIENCES INC

NBIX Clue Score82

United States Fiscal year ends December CIK 0000914475 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

27 insiders · 751 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kevin Charles Gorman

Director

—

$172.84M (56) scheduled

−$172.84M

517,797

0.5094%

$87.27M

−2.8%

Haig P. Bozigian

Chief Development Officer

—

$48.55M (57) scheduled

−$48.55M

157,651

0.1551%

$26.57M

−11.6%

Eric Benevich

Chief Commercial Officer

—

$47.31M (61) scheduled

−$47.31M

67,297

0.0662%

$11.34M

−52.3%

Kyle Gano

Chief Executive Officer

—

$43.53M (61) scheduled

−$43.53M

155,010

0.1525%

$26.12M

−27.9%

Dimitri E. Grigoriadis

Chief Research Officer

—

$43.06M (46) scheduled

−$43.06M

82,273

0.0809%

$13.87M

−56.5%

Darin Lippoldt

Chief Legal Officer

—

$35.52M (78) scheduled

−$35.52M

56,793

0.0559%

$9.57M

−52.9%

Eiry Roberts

Chief Medical Officer

—

$21.23M (40) scheduled

−$21.23M

35,640

0.0351%

$6.01M

−63.6%

Gary A Lyons

Director

—

$21.05M (23) scheduled

−$21.05M

122,141

0.1202%

$20.58M

−35.8%

Julie Cooke

Chief Human Resources Officer

—

$20.50M (54) scheduled

−$20.50M

24,025

0.0236%

$4.05M

−67.7%

Stephen A Sherwin

Director

—

$18.51M (13) scheduled

−$18.51M

14,860

0.0146%

$2.50M

−50.5%

Malcolm Lloyd-Smith

Chief Integration Officer

—

$17.75M (45) scheduled

−$17.75M

42,337

0.0417%

$7.14M

−59.6%

Jude Onyia

Chief Scientific Officer

—

$16.15M (15) scheduled

−$16.15M

22,647

0.0223%

$3.82M

−18.5%

Christopher Flint OBrien

Former Chief Medical Officer

—

$15.81M (16) scheduled

−$15.81M

55,946

0.0550%

$9.43M

−47.0%

Matt Abernethy

Chief Financial Officer

—

$15.33M (35) scheduled

−$15.33M

42,808

0.0421%

$7.21M

−53.6%

William H Rastetter

Director

—

$13.07M (10) scheduled

−$13.07M

43,678

0.0430%

$7.36M

—

Richard F Pops

Director

—

$12.48M (12) scheduled

−$12.48M

37,798

0.0372%

$6.37M

+144.4%

George J Morrow

Director

—

$10.06M (15) scheduled

−$10.06M

10,386

0.0102%

$1.75M

—

Ingrid Delaet

Chief Regulatory Officer

—

$8.91M (35) scheduled

−$8.91M

18,289

0.0180%

$3.08M

+51.1%

David W. Boyer

Chief Corp. Affairs Officer

—

$6.26M (29) scheduled

−$6.26M

8,722

0.0086%

$1.47M

−81.5%

Leslie Norwalk V

Director

—

$3.22M (7) scheduled

−$3.22M

2,430

0.0024%

$409.53K

—

Corinne H Nevinny

Director

—

$685.53K (2)

−$685.53K

43,283

0.0426%

$7.29M

+69.4%

Timothy Coughlin

Chief Financial Officer

—

$252.40K (4)

−$252.40K

137,961

0.1357%

$23.25M

−4.1%

Shalini Sharp

Director

—

$156.94K (1) scheduled

−$156.94K

4,088

0.0040%

$688.96K

—

Joseph A Mollica

Director

—

—

—

56,042

0.0551%

$9.44M

+50.0%

Johanna Mercier

Director

—

—

—

6,853

0.0067%

$1.15M

—

Christine A Poon

Director

—

—

—

4,753

0.0047%

$801.03K

—

Sanjay Chandru Keswani

Chief Medical Officer

—

—

—

3,281

0.0032%

$552.96K

—